73 related articles for article (PubMed ID: 20228039)
1. Effect of drug content and agglomerate size on tabletability and drug release characteristics of bromhexine hydrochloridetalc agglomerates prepared by crystallo-co-agglomeration.
Jadhav N; Pawar A; Paradkar A
Acta Pharm; 2010 Mar; 60(1):25-38. PubMed ID: 20228039
[TBL] [Abstract][Full Text] [Related]
2. Design and evaluation of deformable talc agglomerates prepared by crystallo-co-agglomeration technique for generating heterogeneous matrix.
Jadhav N; Pawar A; Paradkar A
AAPS PharmSciTech; 2007 Jul; 8(3):E59. PubMed ID: 17915809
[TBL] [Abstract][Full Text] [Related]
3. Development of High-Strength Extended-Release Multiparticulate System by Crystallo-co-agglomeration Technique with Integration of Central Composite Design.
Gaikwad VL; Jadhav NR; Pawar AP; Mahadik KR
AAPS PharmSciTech; 2019 May; 20(5):192. PubMed ID: 31115715
[TBL] [Abstract][Full Text] [Related]
4. Agglomeration of Ibuprofen with talc by novel crystallo-co-agglomeration technique.
Pawar A; Paradkar A; Kadam S; Mahadik K
AAPS PharmSciTech; 2004 Sep; 5(4):e55. PubMed ID: 15760052
[TBL] [Abstract][Full Text] [Related]
5. Influence of polymers/excipients on development of agglomerated crystals of secnidazole by crystallo-co-agglomeration technique to improve processability.
Raval MK; Sorathiya KR; Chauhan NP; Patel JM; Parikh RK; Sheth NR
Drug Dev Ind Pharm; 2013 Mar; 39(3):437-46. PubMed ID: 22380546
[TBL] [Abstract][Full Text] [Related]
6. Preparation and evaluation of talc agglomerates obtained by wet spherical agglomeration as a substrate for coating.
Jadhav NR; Pawar AP; Paradkar AR
Pharm Dev Technol; 2011 Apr; 16(2):152-61. PubMed ID: 20105058
[TBL] [Abstract][Full Text] [Related]
7. Preparation of sustained release matrix pellets by melt agglomeration in the fluidized bed: influence of formulation variables and modelling of agglomerate growth.
Pauli-Bruns A; Knop K; Lippold BC
Eur J Pharm Biopharm; 2010 Mar; 74(3):503-12. PubMed ID: 20026401
[TBL] [Abstract][Full Text] [Related]
8. Crystallo-co-agglomeration: a novel technique to obtain ibuprofen-paracetamol agglomerates.
Pawar AP; Paradkar AR; Kadam SS; Mahadik KR
AAPS PharmSciTech; 2004 Jun; 5(3):e44. PubMed ID: 15760077
[TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of agglomerated crystals by crystallo-co-agglomeration: an integrated approach of principal component analysis and Box-Behnken experimental design.
Garala KC; Patel JM; Dhingani AP; Dharamsi AT
Int J Pharm; 2013 Aug; 452(1-2):135-56. PubMed ID: 23684660
[TBL] [Abstract][Full Text] [Related]
10. Effect of preparation method on compactability of paracetamol granules and agglomerates.
Fichtner F; Rasmuson AC; Alander EM; Alderborn G
Int J Pharm; 2007 May; 336(1):148-58. PubMed ID: 17196775
[TBL] [Abstract][Full Text] [Related]
11. Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates.
Usha AN; Mutalik S; Reddy MS; Ranjith AK; Kushtagi P; Udupa N
Eur J Pharm Biopharm; 2008 Oct; 70(2):674-83. PubMed ID: 18606224
[TBL] [Abstract][Full Text] [Related]
12. Sucrose esters with various hydrophilic-lipophilic properties: novel controlled release agents for oral drug delivery matrix tablets prepared by direct compaction.
Chansanroj K; Betz G
Acta Biomater; 2010 Aug; 6(8):3101-9. PubMed ID: 20132913
[TBL] [Abstract][Full Text] [Related]
13. Particle size distribution and evolution in tablet structure during and after compaction.
Fichtner F; Rasmuson A; Alderborn G
Int J Pharm; 2005 Mar; 292(1-2):211-25. PubMed ID: 15725568
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic evaluation of binary effects of magnesium stearate and talc as dissolution retardants at 85% drug loading in an experimental extended-release formulation.
Dürig T; Fassihi R
J Pharm Sci; 1997 Oct; 86(10):1092-8. PubMed ID: 9344163
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a matrix tablet prepared with polyacrylamide-g-sodium alginate co-polymers and their partially hydrolyzed co-polymers for sustained release of diltiazem hydrochloride.
Mandal S; Ray R; Basu SK; Sa B
J Biomater Sci Polym Ed; 2010; 21(13):1799-814. PubMed ID: 20557689
[TBL] [Abstract][Full Text] [Related]
16. Influence of excipients and processing conditions on the development of agglomerates of racecadotril by crystallo-co-agglomeration.
Garala K; Patel J; Patel A; Raval M; Dharamsi A
Int J Pharm Investig; 2012 Oct; 2(4):189-200. PubMed ID: 23580935
[TBL] [Abstract][Full Text] [Related]
17. Preparation and in-vitro evaluation of sustained-release metoclopramide hydrochloride microspheres.
Khidr SH; Niazy EM; el-Sayed YM
J Microencapsul; 1995; 12(6):651-60. PubMed ID: 8558387
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the effect of some additives on the efficiency of binder liquid in wet agglomeration of crystals.
Maghsoodi M; Nabizadeh H; Nokhodchi A
Pharm Dev Technol; 2017 Sep; 22(6):827-835. PubMed ID: 27387408
[TBL] [Abstract][Full Text] [Related]
19. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
[TBL] [Abstract][Full Text] [Related]
20. A novel co-processing method to manufacture an API for extended release formulation via formation of agglomerates of active ingredient and hydroxypropyl methylcellulose during crystallization.
Rosenbaum T; Erdemir D; Chang SY; Kientzler D; Wang S; Chan SH; Brown J; Hanley S; Kiang S
Drug Dev Ind Pharm; 2018 Oct; 44(10):1606-1612. PubMed ID: 29916275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
